References
- Zhao SP, Li XP. The association of low plasma testosterone level with coronary artery disease in Chinese men. Int J Cardiol 1998; 63: 161–64
- Simon D, Charles M, Nahoul K, et al. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: the Telecom Study. J Clin Endocrinol Metab 1997; 82: 682–85
- English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS. Men with coronary artery disease have lower levels of testosterone than those with normal coronary angiograms. Eur Heart J 2000; 21: 890–95
- Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med 1993; 328: 1069–75
- Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med 1989; 321: 641–46
- Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C. Natural androgens inhibit male atherosclerosis. A study of castrated, cholesterol fed rabbits. Circ Res 1999; 84: 813–19
- Maffei S, De Caterina R. Hormone replacement therapy and cardiovascular risk. G Ital Cardiol 1996; 26: 899–940
- English KM, Steeds R, Jones TH, Channer KS. Testosterone and ischemic heart disease: is there a link?. QJM 1997; 90: 787–91
- Massafra C, De Felice C, Gioia D, Buonocore G. Variations in erythrocyte antioxidant glutathione peroxidase activity during the menstrual cycle. Clin Endocrinol (oxf) 1998; 49: 63–67
- Massafra C, Gioia D, De Felice C, Picciolini E, De Leo V, Bonifazi M, Bernabei A. Effects of estrogens and androgens on erythrocyte antioxidant superoxide dismutase, catalase and glutathione peroxidase activities during the menstrual cycle. J Endocrinol 2000; 167: 447–52
- Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001; 54: 176–86
- Young IS, McEneny J. Lipoprotein oxidation and atherosclerosis. Biochem Soc Transact 2001; 29: 358–62
- Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull 1993; 49: 566–76
- Tribouilloy CM, Peltier M, Iannetta-Peltier MC, Zhu Z, Andrejak M, Lesbre JP. Relation between low-density lipoprotein cholesterol and thoracic aortic atherosclerosis. Am J Cardiol 1999; 84: 603–05
- Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112–19
- Ayres S, Tang M, Subbiah MT. Estradiol-17 beta as an antioxidant: some distinct features when compared with common fat-soluble antioxidants. J Lab Clin Med 1996; 128: 367–75
- Laloraya M, Jain S, Thomas M, Kopergaonkar S, Pradeep Kumar G. Estrogen surge: a regulatory switch for superoxide radical generation at implantation. Biochem Mol Biol Int 1996; 39: 933–40
- Bekesi G, Kakucs R, Varbiro S, Racz K, Sprintz D, Feher J, et al. In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes. Steroids 2000; 65: 889–94
- Arnal JF, Clamens S, Pechet C, et al. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci USA 1996; 93: 4108–13
- Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988; 115: 954–63